文献速递主动脉疾病

腹主动脉瘤腔内修复术后初始两日血压管理通过降低早期II型内漏发生率改善中期结局

Initial two-day blood pressure management after endovascular aneurysm repair improves midterm outcomes by reducing the incidence of early type II endoleak.
PubMed 文献 · J Vasc Surg · 2023-10-10

单中心研究纳入2008至2014年137例腹主动脉瘤腔内修复术患者,治疗组76例术后初始24小时平均血压维持75至90 mmHg、随后24小时收缩压低于120 mmHg,对照组60例未行血压管理。治疗组7天II型内漏发生率19.7%对40.0%(P=.009),1年及2年瘤囊直径平均缩小幅度更大,5年无瘤囊增大生存率83.0%对70.0%(P=.021)。

要点

  • 术后初始两日血压管理组7天II型内漏发生率19.7%,低于对照组40.0%(P=.009)。
  • 治疗组1年瘤囊直径平均缩小5.1±4.9 mm,对照组缩小2.2±6.7 mm(P=.013)。
  • 使用Gore Excluder时治疗组7天II型内漏22.7%,对照组80.0%(P<.001)。

核心结论

  • 术后初始两日血压管理通过降低腔内修复术后7天II型内漏发生率,对瘤囊增大发挥预防作用并持续至中期。
  • 在血压管理下使用Gore Excluder与持续至中期随访的阳性效应相关。

研究设计与样本

  • 单中心系列研究,2008至2014年共回顾137例因腹主动脉瘤行腔内修复术的患者。
  • 治疗组76例自2013年起术后初始24小时平均血压维持75至90 mmHg,随后24小时收缩压控制低于120 mmHg。
  • 对照组60例为2013年前连续接受标准腔内修复术而未行血压管理的患者。

主要发现

  • 治疗组与对照组7天II型内漏发生率分别为19.7%与40.0%(P=.009)。
  • 治疗组与对照组1年瘤囊直径平均缩小分别为5.1±4.9 mm与2.2±6.7 mm(P=.013),2年分别为5.4±7.7 mm与1.7±10.8 mm(P=.045)。
  • 使用Gore Excluder时治疗组7天II型内漏发生率为22.7%,对照组为80.0%(P<.001),并带来术后至4年瘤囊直径的显著减小。
  • 治疗组与对照组5年无瘤囊增大生存率分别为83.0%与70.0%(P=.021),治疗组显著更高。
  • 两组再干预、II型内漏相关再干预及全因死亡的免于干预率无显著差异。

临床怎么用

  • 作者认为术后初始两日血压管理对瘤囊增大具有预防作用并可持续至中期。
  • 作者认为在血压管理下使用Gore Excluder与持续至中期随访的阳性效应相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to evaluate midterm outcomes of our novel strategy of postoperative initial 2-day blood pressure management (BPM) after endovascular aneurysm repair (EVAR) for the prevention of subsequent type II endoleak (T2EL) in a single-center series. METHODS: Between 2008 and 2014, 137 patients who underwent EVAR for abdominal aortic aneurysm (AAA) were reviewed. Starting from 2013, the mean blood pressure was maintained between 75 and 90 mmHg for the initial 24 hours after EVAR followed by systolic pressure controlled below 120 mmHg during the next 24 hours in the treatment group (n = 76). The incidence of T2EL detected at 7 days, reintervention, and AAA sac diameter up to 5 years after EVAR were compared with those of the control group comprising of 60 consecutive patients who underwent standard EVAR without BPM prior to 2013. RESULTS: Between the treatment group and the control group, significant differences were achieved in the incidence of T2EL at 7 days (19.7% vs 40.0%; P = .009), a mean decrease of AAA sac diameter at 1-year (-5.1 ± 4.9 vs -2.2 ± 6.7 mm; P = .013) and 2-year (-5.4 ± 7.7 vs -1.7 ± 10.8 mm; P = .045). In addition, there was a significant decrease in the incidence of T2EL detected at 7 days with the use of the Gore Excluder with 22.7% in the treatment group vs 80.0% in the control group (P < .001), which resulted in a significant decrease in the aneurysm sac diameter up to 4 years after EVAR. Survival rate without AAA sac enlargement at 5 years after EVAR (83.0% vs 70.0%; P = .021) in the treatment group was significantly higher than that of the control group, whereas no significant differences were observed in the freedom rates of reintervention, T2EL-related reintervention, and all-cause mortality between the groups. CONCLUSIONS: Postoperative initial 2-day BPM had a preventive effect on AAA sac enlargement until midterm periods, by reducing the incidence of T2EL at 7 days after EVAR. The usage of Gore Excluder under BPM was especially associated with sustained positive effects until the midterm follow-up.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Miura S, Kurimoto Y, Maruyama R, et al. Initial two-day blood pressure management after endovascular aneurysm repair improves midterm outcomes by reducing the incidence of early type II endoleak. J Vasc Surg. 2023. PMID: 37827245. doi:10.1016/j.jvs.2023.10.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。